Pharmaceutical Processing World

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards

COVID-19 vaccine hesitancy rates remain high 

By Brian Buntz | February 11, 2021

Image courtesy of Unsplash

While estimates vary, achieving herd immunity against COVID-19 will likely require vaccinating at least 70% to 80% of the public, if not more. Some diseases, like measles, require a vaccination rate of 95%, according to the World Health Organization.

Yet, many people in the U.S. public remains guarded about COVID-19 vaccines. Almost one out of three Americans say they definitely or probably wouldn’t get vaccinated, according to a recent survey from The Associated Press-NORC Center for Public Affairs Research. A total of 15% were certain they wouldn’t get vaccinated.

Kaiser Family Foundation research from December found that 27% of the public remains vaccine-hesitant.

A survey from late last year found that 58% of adults aged 50 to 80 would be somewhat or very likely to get a COVID-19 vaccine.

Ultimately, vaccine hesitancy could be a bigger challenge to herd immunity than the current vaccine shortfalls, argued Dr. Scott Gottlieb, former FDA commissioner, in The Wall Street Journal. By April, it is possible that “supply will start exceeding demand,” Gottlieb wrote. “The challenge won’t be how to ration a scarce resource, but how to reach patients reluctant to get vaccinated.”

The most common reason for the reluctance is concern about COVID-19 vaccines’ safety and efficacy. Some 59% of people who are vaccine-hesitant worry about side effects.

Vaccine misinformation is also rampant. Facebook recently announced plans to crack down on false information related to COVID-19 vaccines.

There is, however, reason for optimism. Attitudes toward vaccines are improving in many parts of the world, according to Nature.

Comments

  1. Kelly Thomas says

    February 17, 2021 at 12:04 am

    I got the Moderna vaccine. The second shot worked me over, headache, body aches, temperature and nauseated. If you want me to ever take another one, the side effects must be minimized.

    Reply
  2. KMBNette says

    February 17, 2021 at 4:19 pm

    I got the second dose of the Pfizer vaccine yesterday and aside from a sore arm this morning and some chills and tiredness late last night, side effects seem to be minimal. Everyone’s immune system is different, so they may get slightly different reactions, but it seems that the side effects are insignificant compared to getting severe COVID.

    Reply

Tell Us What You Think! Cancel reply

Related Articles Read More >

Moscow
Moscow ramping up COVID-19 vaccination
Johnson & Johnson
FDA authorizes J&J’s single-dose COVID-19 vaccine
President Joe Biden
Biden to order analysis of pharma supply chain
COVID-19 vaccine
5 takeaways from the latest White House COVID-19 response team briefing

DeviceTalks Tuesdays

DeviceTalks Tuesdays

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.

Need Pharmaceutical Processing news in a minute?

We Deliver!
Pharmaceutical Processing Enewsletters get you caught up on all the mission critical news you need. Sign up today.
Enews Signup

R&D Twitter

Tweets by @RandDWorld
Pharmaceutical Processing World
  • Enews Signup
  • Contact Us
  • About Us
  • R&D World
  • DeviceTalks
  • Drug Discovery & Development
  • Drug Delivery Business News
  • MassDevice
  • Medical Design Sourcing

Copyright © 2021 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Pharmaceutical Processing

  • Home
  • Regulatory
    • Recalls
  • Pharmaceutical Processing
  • Facility
  • Supply Chain
  • Enterprise Technology
  • Contract Manufacturing
  • R&D 100 Awards